Levomepromazine Catalog No.:M27997-C Decoupling Activation of Heme Biosynthesis

Decoupling Activation of Heme Biosynthesis From Anaerobic Toxicity in a Molecule Active in Staphylococcus Aureus

and 80% of the initial population of MDA-MB-468

Smiles: C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C4(C)C)[C@]3(C)[C@H](O)C[C@@]21C

Exploring the mechanism of action of TG101209 indicated downregulation of pJak2

Alain Beck

Levomepromazine Catalog No.:M27997-C Decoupling Activation of Heme BiosynthesisLevomepromazine (Methotrimeprazine) is an orally available neuroleptic agent, which is commonly used to relieve nausea and vomiting in palliative care settings. Levomepromazine has antagonist actions at multiple neurotransmitter receptor sites, including dopaminergic, cholinergic, serotonin and histamine receptors. Product information CAS Number: 60 99 1 Molecular Weight: 328. 47 Formula: C19H24N2OS Chemical Name: [(2R) 3 (2 methoxy 10H phenothiazin